Can Anti-TNFα Antibodies Affect SARS-CoV-2 Disease Outcomes?
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 423, doi. 10.34172/apb.2022.066
- By:
- Publication type:
- Article
Works matching IS 22285881 AND DT 2022 AND VI 12 AND IP 3
Results: 22
1
2
Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 466, doi. 10.34172/apb.2022.050
- By:
- Publication type:
- Article
3
Successful Application of Alpha Lipoic Acid Niosomal Formulation in Cerebral Ischemic Reperfusion Injury in Rat Model.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 541, doi. 10.34172/apb.2022.058
- By:
- Publication type:
- Article
4
Sclareol Inhibits Hypoxia-Inducible Factor-1α Accumulation and Induces Apoptosis in Hypoxic Cancer Cells.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 593, doi. 10.34172/apb.2022.062
- By:
- Publication type:
- Article
5
Polymeric Hydrogel Scaffolds: Skin Tissue Engineering and Regeneration.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 437, doi. 10.34172/apb.2022.069
- By:
- Publication type:
- Article
6
Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 583, doi. 10.34172/apb.2022.061
- By:
- Publication type:
- Article
7
CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 476, doi. 10.34172/apb.2022.051
- By:
- Publication type:
- Article
8
Conditioned Medium of Adipose-Derived Mesenchymal Stem Cells as a Promising Candidate to Protect High Glucose-Induced Injury in Cultured C28I2 Chondrocytes.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 632, doi. 10.34172/apb.2022.044
- By:
- Publication type:
- Article
9
Combination Therapy of Metadichol Nanogel and Lipocalin-2 Engineered Mesenchymal Stem Cells Improve Wound Healing in Rat Model of Excision Injury.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 550, doi. 10.34172/apb.2022.059
- By:
- Publication type:
- Article
10
An Overview of Antimicrobial Properties of Carbon Nanotubes-Based Nanocomposites.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 449, doi. 10.34172/apb.2022.049
- By:
- Publication type:
- Article
11
Clinical Application Study of Polymeric Nanospheres Network in Methylphenidate Extraction from Urine Samples by Dispersive Solid Phase Extraction Adsorbent.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 561, doi. 10.34172/apb.2022.054
- By:
- Publication type:
- Article
12
Design and Development of Antibacterial/Anti-inflammatory Dual Drug-Loaded Nanofibrous Inserts for Ophthalmic Sustained Delivery of Gentamicin and Methylprednisolone: In Vitro Bioassay, Solvent, and Method Effects' Evaluation.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 531, doi. 10.34172/apb.2022.056
- By:
- Publication type:
- Article
13
Novel Chronic Wound Healing by Anti-biofilm Peptides and Protease.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 424, doi. 10.34172/apb.2022.047
- By:
- Publication type:
- Article
14
Multiplex NanoSPR Molecular Biosensor for Blood Cytokine Monitoring.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 419, doi. 10.34172/apb.2022.046
- By:
- Publication type:
- Article
15
Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 509
- By:
- Publication type:
- Article
16
5FU-loaded PCL/Chitosan/Fe3O4 Core-Shell Nanofibers Structure: An Approach to Multi-Mode Anticancer System.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 568, doi. 10.34172/apb.2022.060
- By:
- Publication type:
- Article
17
Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 515, doi. 10.34172/apb.2022.057
- By:
- Publication type:
- Article
18
The Effect of Spironolactone on β-amyloid-Induced Memory Impairment in Male Rats: The Role of Microglial Inhibition.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 623, doi. 10.34172/apb.2022.065
- By:
- Publication type:
- Article
19
Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 613, doi. 10.34172/apb.2022.064
- By:
- Publication type:
- Article
20
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 490, doi. 10.34172/apb.2022.052
- By:
- Publication type:
- Article
21
Melanoma Cancer Therapy Using PEGylated Nanoparticles and Semiconductor Laser.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 524, doi. 10.34172/apb.2022.055
- By:
- Publication type:
- Article
22
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 603, doi. 10.34172/apb.2022.063
- By:
- Publication type:
- Article